Matthew Buten

Matthew Buten is the Chief Financial Officer at Biohaven, bringing over two decades of experience in healthcare investing and investment banking to the role. Prior to joining Biohaven, he served as a Managing Director at Foresite Capital from 2012 to 2021 and worked as a healthcare portfolio manager at Millennium Partners, where he managed between $400 million and $600 million in long/short market-neutral capital. His earlier career includes tenures as Managing Director and Head of Healthcare Investment Banking at Needham & Company, as well as an equity analyst role at Argus Partners supporting a $1 billion healthcare fund. He holds a Bachelor of Science in economics from the Wharton School of the University of Pennsylvania. Buten's professional background centers on structuring financial transactions and managing significant investment portfolios across the pharmaceutical, medical technology, and healthcare services sectors.